Targeting RAS proteins may prevent relapse in acute myeloid Leukaemia
Relapses in a common form of leukaemia may be preventable following new research which has…
Browsing: RAS
Opening a new front against pancreatic cancer
A new type of investigational therapeutic in development for pancreatic cancer has shown unprecedented tumour-fighting…
Cancer cells alter cell competition to enhance their own invasive ability
Living cells compete with each other and try to adapt to the local environment. Cells…
Lung cancer gene signatures may predict response to chemotherapy
Researchers at the Francis Crick Institute in the UK have developed a method that could…
New protein complex structure reveals possible ways to target key cancer pathway
Some of the most infamous drivers of cancer are mutations in RAS genes, which lead…
Improving drug options for colorectal cancer patients
Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim…
RAS inhibitors for use in targeting more cancers
New findings by UT Southwestern researchers in the USA help better understand the how one…
Postmenopausal bleeding may be a sign of endometrial cancer in obese Asian women
The link between obesity and the risk of endometrial cancer has been well documented. A…
New treatment options for deadliest of cancers
A new way to target a mutant protein which can cause the deadliest of cancers…
Mutant gene-targeted immunotherapy approach developed
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory,…